# Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-dulaglutide-added-onto-pioglitazone-and-metformin-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Carol Wysham,Thomas Blevins,Richard F. Arakaki,Gildred Colon,Pedro García,Charles Atisso,Debra Kuhstoss,Mark Lakshmanan |
| Citations | 390 |
| DOI | 10.2337/dc13-2760 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2104252114 |
| PMID | 24879836 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Mark Lakshmanan](https://scholariq.org/researchers/mark-lakshmanan/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.